<!DOCTYPE html>

<html lang="en">
<head>
<meta charset="utf-8"/>
<meta content="width=device-width, initial-scale=1.0" nameag="viewport"/>
<title>Diabetes Mellitus (Part 2)</title>
<script src="https://cdn.tailwindcss.com"></script>
<script src="https://cdn.jsdelivr.net/npm/hls.js@latest"></script>
<script src="https://cdn.jsdelivr.net/npm/canvas-confetti@1.6.0/dist/confetti.browser.min.js"></script>
<style>
        /* Custom styles for enhanced aesthetics and responsiveness */
        .option-btn {
            transition: all 0.3s ease;
            box-shadow: 0 2px 4px rgba(0, 0, 0, 0.1);
        }
        .option-btn:hover, .option-btn:active {
            transform: scale(1.02);
            box-shadow: 0 4px 8px rgba(0, 0, 0, 0.2);
        }
        .option-btn.selected {
            background-color: #3b82f6;
            color: white;
        }
        .marked {
            background-color: #fef08a;
        }
        .progress-bar {
            transition: width 0.5s ease-in-out;
            background: linear-gradient(to right, #3b82f6, #22c55e);
            box-shadow: 0 2px 4px rgba(0, 0, 0, 0.2);
            animation: pulse 2s infinite;
        }
        @keyframes pulse {
            0% { opacity: 1; }
            50% { opacity: 0.8; }
            100% { opacity: 1; }
        }
        .question-nav-btn, .result-nav-btn-grid {
            width: 40px;
            height: 40px;
            display: flex;
            align-items: center;
            justify-content: center;
            border-radius: 8px;
            font-size: 16px;
            touch-action: manipulation;
            transition: all 0.2s ease;
        }
        .question-nav-btn:hover, .question-nav-btn:active, .result-nav-btn-grid:hover, .result-nav-btn-grid:active {
            transform: scale(1.05);
        }
        .answered {
            background-color: #22c55e;
            color: white;
        }
        .unanswered {
            background-color: #e5e7eb;
        }
        .marked-nav {
            border: 2px solid #fef08a;
        }
        .video-container, .audio-container {
            display: none;
            position: relative;
        }
        .video-container.active, .audio-container.active {
            display: block;
            animation: fadeIn 0.5s ease-in;
        }
        @keyframes fadeIn {
            from { opacity: 0; }
            to { opacity: 1; }
        }
        .section-transition {
            transition: opacity 0.3s ease;
        }
        .section-transition.hidden {
            opacity: 0;
            pointer-events: none;
        }
        .result-nav {
            display: flex;
            justify-content: space-between;
            align-items: center;
            margin-top: 1rem;
        }
        .result-nav-btn {
            background-color: #4b5563;
            color: white;
            padding: 0.5rem 1rem;
            border-radius: 8px;
            transition: all 0.2s ease;
        }
        .result-nav-btn:hover, .result-nav-btn:active {
            background-color: #374151;
            transform: scale(1.05);
        }
        .result-nav-btn:disabled {
            background-color: #d1d5db;
            cursor: not-allowed;
        }
        .error-message {
            color: #dc2626;
            font-weight: bold;
            margin-top: 1rem;
        }
        /* Mobile-specific adjustments */
        @media (max-width: 640px) {
            .question-nav-btn, .result-nav-btn-grid {
                width: 38px;
                height: 38px;
                font-size: 14px;
            }
            .nav-panel, .results-nav-panel {
                width: 100%;
                max-width: 100%;
                overscroll-behavior: contain;
            }
            .option-btn {
                padding: 12px;
                font-size: 14px;
            }
            .header-text {
                font-size: 1.5rem;
            }
            .subheader-text {
                font-size: 0.875rem;
            }
            .button-group, .result-nav {
                flex-direction: column;
                gap: 0.5rem;
            }
            .result-nav-btn {
                width: 100%;
                text-align: center;
            }
        }
        /* Dark mode styles */
        .dark .bg-gray-100 {
            background-color: #1f2937;
        }
        .dark .bg-white {
            background-color: #374151;
        }
        .dark .text-gray-700 {
            color: #d1d5db;
        }
        .dark .text-gray-800 {
            color: #e5e7eb;
        }
        .dark .bg-gray-200 {
            background-color: #4b5563;
        }
        .dark .border {
            border-color: #4b5563;
        }
        .dark .bg-blue-500 {
            background-color: #2563eb;
        }
        .dark .hover\:bg-blue-600:hover {
            background-color: #1d4ed8;
        }
        .dark .bg-yellow-300 {
            background-color: #b45309;
            color: white;
        }
        .dark .hover\:bg-yellow-400:hover {
            background-color: #92400e;
        }
        .dark .bg-green-500 {
            background-color: #15803d;
        }
        .dark .hover\:bg-green-600:hover {
            background-color: #166534;
        }
        .dark .bg-gray-500 {
            background-color: #4b5563;
        }
        .dark .hover\:bg-gray-600:hover {
            background-color: #374151;
        }
        .dark .result-nav-btn, .dark .result-nav-btn-grid {
            background-color: #2563eb;
        }
        .dark .result-nav-btn:hover, .dark .result-nav-btn:active, .dark .result-nav-btn-grid:hover, .dark .result-nav-btn-grid:active {
            background-color: #1d4ed8;
        }
        .dark .result-nav-btn:disabled, .dark .result-nav-btn-grid:disabled {
            background-color: #4b5563;
        }
        .video-placeholder {
            width: 400px;
            height: 300px;
            background-color: #f0f0f0;
            display: flex;
            align-items: center;
            justify-content: center;
            cursor: pointer;
            margin-top: 10px;
            border-radius: 8px;
            border: 1px solid #ccc;
        }
        .play-icon {
            font-size: 40px;
            color: #007bff;
        }
        .video-loading {
            position: absolute;
            top: 50%;
            left: 50%;
            transform: translate(-50%, -50%);
            border: 4px solid #f3f3f3;
            border-top: 4px solid #3b82f6;
            border-radius: 50%;
            width: 40px;
            height: 40px;
            animation: spin 1s linear infinite;
        }
        @keyframes spin {
            0% { transform: translate(-50%, -50%) rotate(0deg); }
            100% { transform: translate(-50%, -50%) rotate(360deg); }
        }
    </style>

<script>
    // --- GEMINI AUTO-CAPTURE LISTENER ---
    // This function runs immediately after the quiz determines an answer is INCORRECT.
    function captureMistake(questionIndex, questionsData) {
        try {
            const item = questionsData[questionIndex];
            // Use the question text as a unique, stable identifier
            const uniqueId = 'srs_quiz_' + btoa(item.text.substring(0, 50)).replace(/=/g, ''); 

            // 1. Clean and simplify the explanation for storage
            let explanationText = item.explanation || item.correct_answer || "No explanation provided.";
            
            // Strip complex HTML (images, lists) and boilerplate text
            explanationText = explanationText.replace(/<img[^>]*>/g, "[IMAGE]").trim(); // Replace images with placeholder
            explanationText = explanationText.replace(/<p><strong>Ans\. [A-Z]\).*/i, "").trim(); // Remove the repeated Answer line
            explanationText = explanationText.replace(/<p><strong>Educational Objective:<\/strong>.*?<\/p>/gs, "").trim(); // Remove EO block
            explanationText = explanationText.replace(/@dams_new_robot/g, "");
            explanationText = explanationText.replace(/<\/?[^>]+(>|$)/g, " ").trim(); // Final strip of remaining tags

            // 2. Prepare card data
            const cardData = {
                text: item.text,
                answer: item.correct_answer,
                explanation: explanationText.substring(0, 500), // Keep explanations short
                nextReview: 0, // Due immediately
                reviews: 0,
                source: document.title.split('-')[0].trim() || 'Quiz'
            };

            // 3. Save to Local Storage (SRS Bank)
            localStorage.setItem(uniqueId, JSON.stringify(cardData));
            
            console.log(`üß† Captured Mistake #${questionIndex + 1} from ${document.title}`);

        } catch (e) {
            console.error("SRS Capture Failed:", e);
        }
    }
    // --- END GEMINI AUTO-CAPTURE LISTENER ---
</script>

</head>
<body class="bg-gray-100 font-sans transition-colors duration-300 min-h-screen overflow-y-auto">
<!-- Header Section -->
<header class="bg-blue-600 text-white p-4 shadow-lg">
<div class="container mx-auto">
<h1 class="text-2xl md:text-3xl font-bold header-text">Diabetes Mellitus (Part 2)</h1>
<p class="mt-2 text-sm md:text-base subheader-text">
                22 Questions | 22 Total Marks | 32 min Duration | ~87.27 sec/question
            </p>
<button class="mt-2 bg-gray-200 text-gray-800 px-3 py-1 rounded-lg hover:bg-gray-300 transition dark:bg-gray-600 dark:text-white" id="theme-toggle">
                Toggle Dark Mode
            </button>
</div>
</header>
<!-- Instructions Section -->
<section class="container mx-auto p-4 md:p-6 section-transition" id="instructions">
<div class="bg-white rounded-lg shadow-md p-5 md:p-8 md:p-5 md:p-8 min-h-screen md:min-h-0 md:rounded-lg md:shadow-md rounded-none shadow-none flex flex-col justify-between">
<h2 class="text-xl font-semibold mb-4">Instructions</h2>
<ul class="list-disc list-inside space-y-2 text-gray-700">
<li>This test contains 22 multiple choice questions.</li>
<li>Each question has only one correct answer.</li>
<li>You will have 32 minutes to complete the test.</li>
<li>Click or tap on an option to select your answer.</li>
<li>Use the "Mark for Review" button to revisit questions.</li>
<li>Navigate using Previous/Next buttons or the Questions Navigation panel.</li>
<li>Click "Submit" to finish and view results.</li>
<li>The test will auto-submit when time runs out.</li>
</ul>
<div class="mt-6 flex space-x-4 button-group md:flex-row flex-col">
<button class="bg-blue-500 text-white px-6 py-2 rounded-lg hover:bg-blue-600 transition" id="start-test">Start Test</button>


</div>
<div class="error-message hidden" id="error-message"></div>
</div>
</section>
<!-- Quiz Section -->
<section class="container mx-auto p-4 md:p-6 hidden section-transition" id="quiz">
<div class="bg-white rounded-lg shadow-md p-5 md:p-8 md:p-5 md:p-8 min-h-screen md:min-h-0 md:rounded-lg md:shadow-md rounded-none shadow-none flex flex-col justify-between">
<!-- Progress Bar -->
<div class="w-full bg-gray-200 rounded-full h-3 mb-4">
<div class="progress-bar h-3 rounded-full" id="progress-bar" style="width: 0%"></div>
</div>
<!-- Question Header -->
<div class="flex flex-col md:flex-row justify-between items-center mb-4">
<h2 class="text-lg font-semibold" id="question-number">Question <span>1</span> of 22</h2>
<p class="text-lg font-semibold mt-2 md:mt-0" id="timer">Time Remaining: <span>00:00</span></p>
</div>
<!-- Question Content -->
<div class="mb-6" id="question-content">
<p class="text-gray-800 mb-4" id="question-text"></p>
<div class="flex flex-wrap gap-4 mb-4" id="question-images"></div>
<div class="space-y-3" id="options"></div>
</div>
<!-- Navigation Buttons -->
<div class="flex flex-col md:flex-row justify-between items-center gap-2 md:gap-4">
<button class="bg-gray-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-400 transition w-full md:w-auto" disabled="" id="previous-btn">Previous</button>
<button class="bg-yellow-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-yellow-400 transition w-full md:w-auto" id="mark-review">Mark for Review</button>
<button class="bg-blue-500 text-white px-4 py-2 rounded-lg hover:bg-blue-600 transition w-full md:w-auto" id="next-btn">Next</button>
<button class="bg-gray-500 text-white px-4 py-2 rounded-lg hover:bg-gray-600 transition w-full md:w-auto" id="nav-toggle">Questions Navigation</button>
<button class="bg-green-500 text-white px-4 py-2 rounded-lg hover:bg-blue-600 transition w-full md:w-auto" id="submit-test">Submit Test</button>
</div>
</div>
</section>
<!-- Results Section -->
<section class="container mx-auto p-4 md:p-6 hidden section-transition" id="results">
<div class="bg-white rounded-lg shadow-md p-5 md:p-8 md:p-5 md:p-8 min-h-screen md:min-h-0 md:rounded-lg md:shadow-md rounded-none shadow-none flex flex-col justify-between">
<h2 class="text-2xl font-semibold mb-4">Diabetes Mellitus (Part 2) - Results</h2>
<div class="grid grid-cols-1 md:grid-cols-2 gap-4 mb-6">
<p><strong>Correct:</strong> <span id="correct-count">0</span></p>
<p><strong>Wrong:</strong> <span id="wrong-count">0</span></p>
<p><strong>Unanswered:</strong> <span id="unanswered-count">0</span></p>
<p><strong>Marked for Review:</strong> <span id="marked-count">0</span></p>
</div>
<h3 class="text-lg font-semibold mb-4" id="result-question-number">Question <span>1</span> of 22</h3>
<div class="space-y-6" id="results-content"></div>
<div class="result-nav">
<button aria-label="Previous question result" class="result-nav-btn" disabled="" id="prev-result">Previous</button>
<button aria-label="Toggle results navigation panel" class="result-nav-btn" id="results-nav-toggle">Results Navigation</button>
<button aria-label="Next question result" class="result-nav-btn" id="next-result">Next</button>
</div>
<div class="mt-6 flex space-x-4 button-group md:flex-row flex-col">
<button class="bg-blue-500 text-white px-6 py-2 rounded-lg hover:bg-blue-600 transition" id="take-again">Take Again</button>
<button class="bg-gray-500 text-white px-6 py-2 rounded-lg hover:bg-gray-600 transition" id="review-test">Review Test</button>
</div>
</div>
</section>
<!-- Exit Confirmation Modal -->
<div class="fixed inset-0 bg-black bg-opacity-50 flex items-center justify-center hidden" id="exit-modal">
<div class="bg-white rounded-lg p-6 max-w-sm w-full">
<h2 class="text-xl font-semibold mb-4">Leave Test?</h2>
<p class="text-gray-700 mb-4">Your progress will be lost if you leave this page. Are you sure you want to exit?</p>
<div class="flex justify-end space-x-4">
<button class="bg-gray-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-400 transition" id="continue-test">No, Continue</button>
<button class="bg-red-500 text-white px-4 py-2 rounded-lg hover:bg-red-600 transition" id="exit-test">Yes, Exit</button>
</div>
</div>
</div>
<!-- Submit Confirmation Modal -->
<div class="fixed inset-0 bg-black bg-opacity-50 flex items-center justify-center hidden" id="submit-modal">
<div class="bg-white rounded-lg p-6 max-w-sm w-full">
<h2 class="text-xl font-semibold mb-4">Confirm Submission</h2>
<p class="text-gray-700 mb-2">You have attempted <span id="attempted-count">0</span> of 22 questions.</p>
<p class="text-gray-700 mb-4"><span id="unattempted-count">0</span> questions are unattempted.</p>
<div class="flex justify-end space-x-4">
<button class="bg-gray-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-400 transition" id="cancel-submit">Cancel</button>
<button class="bg-green-500 text-white px-4 py-2 rounded-lg hover:bg-green-600 transition" id="confirm-submit">Submit Test</button>
</div>
</div>
</div>
<!-- Quiz Navigation Panel -->
<div class="fixed inset-y-0 right-0 nav-panel bg-white shadow-lg p-4 hidden overflow-y-auto" id="nav-panel">
<h2 class="text-lg font-semibold mb-4">Questions Navigation</h2>
<div class="mb-4">
<select class="w-full p-2 border rounded-lg text-gray-700" id="nav-filter">
<option value="all">All Questions</option>
<option value="answered">Answered</option>
<option value="unanswered">Unanswered</option>
<option value="marked">Marked for Review</option>
</select>
</div>
<div class="grid grid-cols-5 gap-2 md:gap-3" id="nav-grid"></div>
<button class="mt-4 bg-gray-500 text-white px-4 py-2 rounded-lg hover:bg-gray-600 transition w-full" id="close-nav">Close</button>
</div>
<!-- Results Navigation Panel -->
<div class="fixed inset-y-0 right-0 results-nav-panel bg-white shadow-lg p-4 hidden overflow-y-auto" id="results-nav-panel">
<h2 class="text-lg font-semibold mb-4">Results Navigation</h2>
<div class="mb-4">
<select class="w-full p-2 border rounded-lg text-gray-700" id="results-nav-filter">
<option value="all">All Questions</option>
<option value="answered">Answered</option>
<option value="unanswered">Unanswered</option>
<option value="marked">Marked for Review</option>
</select>
</div>
<div class="grid grid-cols-5 gap-2 md:gap-3" id="results-nav-grid"></div>
<button class="mt-4 bg-gray-500 text-white px-4 py-2 rounded-lg hover:bg-gray-600 transition w-full" id="close-results-nav">Close</button>
</div>
<!-- JavaScript Logic -->
<script>
        // Enable debug mode for detailed logging
        const DEBUG_MODE = true;

        // Log debug messages
        function debugLog(message) {
            if (DEBUG_MODE) {
                console.log(`[DEBUG] ${message}`);
            }
        }

        // Initialize questions with error handling
        let questions = [];
        let currentResultQuestion = 0; // State for current question in results
        try {
            debugLog("Attempting to parse questions_json");
            questions = [{"text": "The majority of cases of diabetes can be broadly classified into 2 categories: type 1 diabetes and type 2 diabetes, although some cases are difficult to classify. Gestational diabetes (GDM) refers to glucose intolerance with onset or first recognition during pregnancy. What is the recent major basis of the classification of DM into types 1 and 2?", "options": [{"label": "A", "text": "Age of onset", "correct": false}, {"label": "B", "text": "Response of insulin therapy", "correct": false}, {"label": "C", "text": "Pathogenic process leading to hyperglycemia", "correct": true}, {"label": "D", "text": "Body mass index", "correct": false}], "correct_answer": "C. Pathogenic process leading to hyperglycemia", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Solution:</strong></p><p>Pathogenic process leading to hyperglycemia DM is classified on the basis of the pathogenic process leading to hyperglycemia , as opposed to earlier criteria such as the age of onset or type of therapy.</p>\n<p><strong>Random:</strong></p><p>Explanation for incorrect options: - Option: A. used in earlier classification. Age or treatment modality is not a criterion. Although type 1 DM most commonly develops before the age of 30, autoimmunity against beta cells can develop at any age. It is estimated that between 5 and 10% of individuals who develop DM after age 30 have type 1 dm. Although type 2 DM more typically develops with increasing age, it is now being diagnosed more frequently in children and young adults, particularly in obese adolescents. Option: B. it was used in earlier classification. The terms insulin-dependent diabetes mellitus (IDDM) or non-insulin-dependent diabetes mellitus (NIDDM) are no longer used. Because many individuals with type 2 DM eventually require insulin treatment for control of glycemia, the use of the term NIDDM generated considerable confusion. Option: D. not the basis.</p>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "Maturity-onset diabetes of the young (MODY), subtypes of DM characterized by all EXCEPT?", "options": [{"label": "A", "text": "Autosomal dominant inheritance", "correct": false}, {"label": "B", "text": "Late onset of hyperglycemia (usually >30 years)", "correct": true}, {"label": "C", "text": "Impaired insulin secretion", "correct": false}, {"label": "D", "text": "Genetic defects of beta cell development or function", "correct": false}], "correct_answer": "B. Late onset of hyperglycemia (usually >30 years)", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Solution:</strong></p><p>Late onset of hyperglycemia (usually >30 years) Maturity-onset diabetes of the young (MODY) and monogenic diabetes are subtypes of DM characterized by early onset of hyperglycemia (usually <25 years; sometimes in neonatal period), and impaired insulin secretion.</p>\n<p><strong>Random:</strong></p><p>Explanation for incorrect options: - Option: A. Maturity-onset diabetes of the young (MODY) and monogenic diabetes are subtypes of DM characterized by autosomal dominant inheritance. Option: C. Maturity-onset diabetes of the young (MODY) is characterized by Impaired insulin secretion is a True statement. Option: D. Maturity-onset diabetes of the young (MODY) is characterized by Genetic defects of beta cell development or function is a True statement.</p>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "Which of the following is true about screening individuals for diabetes mellitus?", "options": [{"label": "A", "text": "For all individuals irrespective of age, screening for DM is repeated every 3 years", "correct": false}, {"label": "B", "text": "For all individuals aged >45 years, screening for DM is repeated every 3 years", "correct": true}, {"label": "C", "text": "Only high-risk individuals aged >45 years, screening for DM repeated every 3 years", "correct": false}, {"label": "D", "text": "For all high-risk individuals irrespective of age, screening for DM is repeated every month", "correct": false}], "correct_answer": "B. For all individuals aged >45 years, screening for DM is repeated every 3 years", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Solution:</strong></p><p>For all individuals aged >45 years, screening for DM is repeated every 3 years The ADA recommends screening all individuals aged >45 years every 3 years and screening individuals at an earlier age if they are overweight (BMI> 25 kg/m2 or ethnically relevant definition for overweight) and have one additional risk factor for diabetes.</p>\n<p><strong>Highyeild:</strong></p><p>Risk Factors for Type 2 Diabetes Mellitus Family history of diabetes (i.e., parent or sibling with type 2 diabetes) Overweight or obese (BMI ‚â•25 kg/m¬≤, 223 kg/m¬≤ in Asian Americans, or other ethnically relevant definition for overweight) Physical inactivity Race/ethnicity (e.g., African American, Latino, Native American, Asian American, Pacific Islander) Previously identified with IFG, IGT, or a haemoglobin A, of 5.7-6.4% History of GDM Hypertension (blood pressure ‚â•140/90 mmHg) HDL cholesterol level <35 mg/dL (0.90 mmol/L) and/or a triglyceride level >250 mg/dL (2.82 mmol/L) Polycystic ovary syndrome or acanthosis nigricans History of cardiovascular disease</p>\n<p><strong>Random:</strong></p><p>Explanation for incorrect options: - Option: A : Aged >45 years. Option: C: Screening individuals at an earlier age if they are overweight (BMI> 25 kg/m2 or ethnically relevant definition for overweight) and have one additional risk factor for diabetes. Option: D: Not needed to screen every month.</p>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "Which of the following criteria is not sufficient for the diagnosis of DM in the absence of symptoms of diabetes mellitus?", "options": [{"label": "A", "text": "Fasting?plasma?glucose??7.0?mmol/l?(126?mg/dl)", "correct": false}, {"label": "B", "text": "Random?blood?glucose?concentration??11.1 mmol/l (200 mg/dl)", "correct": true}, {"label": "C", "text": "Hemoglobin?a1c ? 6.5%", "correct": false}, {"label": "D", "text": "2-h?plasma?glucose??11.1?mmol/l?(200?mg/dl)?during?an?oral?glucose tolerance test", "correct": false}], "correct_answer": "B. Random?blood?glucose?concentration??11.1 mmol/l (200 mg/dl)", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Solution:</strong></p><p>Random?blood?glucose?concentration??11.1 mmol/l (200 mg/dl) Criteria for the diagnosis of diabetes mellitus Symptoms‚ÄÇof‚ÄÇdiabetes‚ÄÇplus‚ÄÇrandom blood‚ÄÇglucose‚ÄÇconcentration‚ÄÇ‚â• 11.1 mmol/l (200 mg/dl) or Fasting‚ÄÇplasma‚ÄÇglucose ‚â• 7.0‚ÄÇmmol/l‚ÄÇ(126‚ÄÇmg/dl) or Haemoglobin A1C ‚â• 6.5% or 2-h‚ÄÇplasma‚ÄÇglucose‚ÄÇ‚â• 11.1‚ÄÇmmol/l‚ÄÇ(200‚ÄÇmg/dl)‚ÄÇduring‚ÄÇan oral‚ÄÇglucose tolerance test.</p>\n<p><strong>Highyeild:</strong></p><p>Criteria for the Diagnosis of Diabetes Mellitus Symptoms of diabetes plus random blood glucose concentration ‚â•11.1 mmol/L (200 mg/dL) a or Fasting plasma glucose ‚â•7.0 mmol/L (126 mg/dL) b or Hemoglobin A‚â• 6.5% c or 2-h plasma glucose ‚â•11.1 mmol/L (200 mg/dL) during an oral glucose tolerance test</p>\n<p><strong>Random:</strong></p><p>Explanation for incorrect options: - Options: A, C, D. sufficient to diagnose DM.</p>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "Shyam 45-year-old diabetic man presented with abdominal pain, and grey pigmentation on his face, neck and dorsum of hands. On examination, you found hepatomegaly and conducted investigations which pointed out towards increased transferrin saturation of 58%. The best mode of treatment, in this case, is?", "options": [{"label": "A", "text": "Deferoxamine", "correct": false}, {"label": "B", "text": "Phlebotomy", "correct": true}, {"label": "C", "text": "Deferasirox", "correct": false}, {"label": "D", "text": "Reduce intake of iron-rich foods", "correct": false}], "correct_answer": "B. Phlebotomy", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Solution:</strong></p><p>Phlebotomy The patient in question has hemochromatosis as evidenced by the findings The therapy of hemochromatosis involves the removal of excess body iron and supportive treatment of damaged organs. Iron removal is best accomplished by weekly or twice-weekly phlebotomy of 500 ml. One 500ml unit of blood removes 200-250 mg of iron. Therefore, in patients with advanced disease, weekly phlebotomy may be required for 1‚Äì2 years, and it should be continued until the serum ferritin level is ‚â§ 100 Œºg/l. Thereafter, phlebotomies are performed at appropriate intervals to maintain ferritin levels at ‚â§ 100 Œºg/l. Thereafter one phlebotomy is sufficient every 3 months It is less expensive, more convenient and safe</p>\n<p><strong>Random:</strong></p><p>Explanation for incorrect options: - Option: A. I.V.Deferoxamine v. Chelating agents like deferoxamine only remove 10-20mg iron/day which is very less compared to phlebotomy Option C - Deferasirox An oral chelating agent is still under clinical trial though available as Exjade Effective in thalassemia and secondary iron overload Option D - Reduce intake of iron-rich foods Intake of vitamin C should be avoided as it increases iron absorption Iron supplements should be avoided</p>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "A 32-year-old male presents with c/o polydipsia and polyuria. He gives an h/o head injury sustained in RTA 3 months ago. The water deprivation test is a diagnostic of central DI. It is characterised by:", "options": [{"label": "A", "text": "Low plasma high urine osmolality", "correct": false}, {"label": "B", "text": "Low plasma low urine osmolality", "correct": false}, {"label": "C", "text": "High plasma high urine osmolality", "correct": false}, {"label": "D", "text": "Low urine high plasma osmolality", "correct": true}], "correct_answer": "D. Low urine high plasma osmolality", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Solution:</strong></p><p>Low urine high plasma osmolality Diabetes insipidus of both central and nephrogenic origin is characterised by low urine and high plasma osmolality with relative hypernatremia</p>\n<p><strong>Random:</strong></p><p>Explanation for incorrect options: - Option A . Low plasma high urine osmolality It is seen in SIADH which is a condition of hyponatremia Option B . Low plasma low urine osmolality Seen in psychogenic polydipsia with hyponatremia Normal urine osmolality: 100-800 mOsm/kg Normal plasma osmolality: 275-295 mOsm/kg In the same way, Option C is also the incorrect option.</p>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "Which of the following insulin can be mixed with other insulin?", "options": [{"label": "A", "text": "Glargine", "correct": false}, {"label": "B", "text": "Degludec", "correct": false}, {"label": "C", "text": "NPH", "correct": true}, {"label": "D", "text": "All of the Above", "correct": false}], "correct_answer": "C. NPH", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Solution:</strong></p><p>NPH The following guidelines should be followed while mixing insulins: mix the different insulin formulations in the syringe immediately before injection (inject within 2 min after mixing); do not store insulin as a mixture; follow the same routine in terms of insulin mixing and administration to standardize the physiologic response to injected insulin ; and do not mix insulin glargine, detemir, or degludec with other insulins. The miscibility of some insulins allows for the production of combination insulins that contain 70% NPH and 30% regular (70/30), or equal mixtures of NPH and regular (50/50). By including the insulin analogue mixed with protamine, several additional combinations have a short-acting and long-acting profile</p>\n<p><strong>Random:</strong></p><p>Explanation for incorrect options: - Option: A, B. Do not mix insulin glargine, detemir, or degludec with other insulins.</p>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "A 36-year diabetic male presents with the following skin lesion. Identify the disorder:", "options": [{"label": "A", "text": "Acanthosis nigricans", "correct": false}, {"label": "B", "text": "Necrobiosis lipoidica", "correct": true}, {"label": "C", "text": "Neuropathic foot ulcer", "correct": false}, {"label": "D", "text": "Gangrene", "correct": false}], "correct_answer": "B. Necrobiosis lipoidica", "question_images": ["https://dbmi-data.s3.ap-south-1.amazonaws.com/photos-1685619366664-QTDM048019IMG1.JPG"], "explanation_images": [], "explanation": "<p><strong>Solution:</strong></p><p>Necrobiosis lipoidica The lesion has a characteristic yellow, waxy, atrophic appearance, often with a violaceous edge. Underlying blood vessels are easily seen because of tissue atrophy. There is a strong association with diabetes: most patients with necrobiosis lipoidica have or develop diabetes, although less than 1% of diabetic patients develop necrobiosis.</p>\n<p><strong>Random:</strong></p><p>Explanation for incorrect options: - Option: A. Hyperkeratosis and pigmentation are typical and affected sites have a velvety texture. The flexures, especially axillae and, in dark-skinned people, sides of the neck, are involved. Option: C. Neuropathic foot ulcer. Option: D. Gangrene</p>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "Which of the following is true about insulin secretion in response to glucose administration via oral and IV routes:", "options": [{"label": "A", "text": "Blue: After Oral glucose and Red: After IV glucose due to incretin secretion in IV glucose load", "correct": false}, {"label": "B", "text": "Blue: After Oral glucose and Red: After IV glucose due to incretin secretion in Oral glucose load", "correct": true}, {"label": "C", "text": "Red: After Oral glucose and Blue: After IV glucose due to incretin secretion in Oral glucose load", "correct": false}, {"label": "D", "text": "Red: After Oral glucose and Blue: After IV glucose due to incretin secretion in IV glucose load", "correct": false}], "correct_answer": "B. Blue: After Oral glucose and Red: After IV glucose due to incretin secretion in Oral glucose load", "question_images": ["https://dbmi-data.s3.ap-south-1.amazonaws.com/photos-1685619369675-QTDM048020IMG1.JPG"], "explanation_images": [], "explanation": "<p><strong>Solution:</strong></p><p>Blue: After Oral glucose and Red: After IV glucose due to incretin secretion in Oral glucose load Incretin is secreted after oral glucose administration which increases insulin release in comparison to IV glucose.</p>\n<p><strong>Random:</strong></p><p>Explanation for incorrect options: - Option: A. Incretin is secreted after oral glucose administration. Options: C, D. Blue: After Oral glucose and Red: After IV glucose.</p>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "Mrs Vani, a 35-year-old, newly detected with diabetes came to you. The treatment goals for adults with diabetes are all of the following, except?", "options": [{"label": "A", "text": "Blood pressure <130/80mmhg", "correct": false}, {"label": "B", "text": "Hba1c<7%", "correct": false}, {"label": "C", "text": "Triglycerides < 150 mg/dl", "correct": false}, {"label": "D", "text": "Peak postprandial capillary plasma glucose < 200 mg/dl", "correct": true}], "correct_answer": "D. Peak postprandial capillary plasma glucose < 200 mg/dl", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Solution:</strong></p><p>Peak postprandial capillary plasma glucose < 200 mg/dl The treatment goal for adults with diabetes is peak postprandial capillary glucose < 180mg/dl and not less than 200mg/dl</p>\n<p><strong>Random:</strong></p><p>Explanation for incorrect options: - Option: A. Blood pressure less than 130/80mmhg. This is a correct statement, the goal is less than 140/80mmhg Option: B. Hba1c less than 7 % This is a correct statement Option: C. Triglycerides < 150 mg/dl- For more than 150 mg/dl triglyceride levels and low HDL, treatment with statins is recommended, although dyslipidemia is not a treatment goal</p>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "A 42-year male patient with Type 2 DM presents in OPD for fundoscopic examination. What is the finding in the fundoscopic Image?", "options": [{"label": "A", "text": "Normal retina", "correct": false}, {"label": "B", "text": "Exudative maculopathy", "correct": false}, {"label": "C", "text": "Proliferative retinopathy", "correct": true}, {"label": "D", "text": "Background retinopathy", "correct": false}], "correct_answer": "C. Proliferative retinopathy", "question_images": ["https://dbmi-data.s3.ap-south-1.amazonaws.com/photos-1685619370013-QTDM048025IMG1.JPG"], "explanation_images": [], "explanation": "<p><strong>Solution:</strong></p><p>Proliferative retinopathy Proliferative retinopathy is seen in this fundoscopy with new vessel proliferation.</p>\n<p><strong>Random:</strong></p><p>Explanation for incorrect options: - Option: A. this image is not normal retina. Option: B. Exudative maculopathy image. Option: D: Background retinopathy</p>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "The renal biopsy of a diabetic patient is shown in the Image. Which of the following is TRUE about the finding?", "options": [{"label": "A", "text": "Thinning of basement membranes, mesangial contraction and a Kimmelstiel-Wilson nodule", "correct": false}, {"label": "B", "text": "Thinning of basement membranes, mesangial expansion and a Kimmelstiel-Wilson nodule", "correct": false}, {"label": "C", "text": "Thickening of basement membranes, mesangial contraction and a Kimmelstiel-Wilson nodule", "correct": false}, {"label": "D", "text": "Thickening of basement membranes, mesangial expansion and a Kimmelstiel-Wilson nodule", "correct": true}], "correct_answer": "D. Thickening of basement membranes, mesangial expansion and a Kimmelstiel-Wilson nodule", "question_images": ["https://dbmi-data.s3.ap-south-1.amazonaws.com/photos-1685619370869-QTDM048027IMG1.JPG"], "explanation_images": [], "explanation": "<p><strong>Solution:</strong></p><p>Thickening of basement membranes, mesangial expansion and a Kimmelstiel-Wilson nodule Nodular diabetic glomerulosclerosis: Pathologically, the first changes coincide with the onset of microalbuminuria and include the thickening of the glomerular basement membrane and the accumulation of matrix material in the mesangium. Subsequently, nodular deposits are characteristic, and glomerulosclerosis worsens as heavy proteinuria develops until glomeruli are progressively lost and renal function deteriorates. There is the thickening of basement membranes, mesangial expansion and a Kimmelstiel‚ÄìWilson nodule (arrow), which is pathognomonic of diabetic kidney disease.</p>\n<p><strong>Random:</strong></p><p>Explanation for incorrect options: - Options: A, B. There is a thickening of basement membranes. Option: C. Mesangial expansion is seen.</p>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "Which nerve is most commonly involved in Nerve compression palsies in diabetic neuropathy?", "options": [{"label": "A", "text": "Median nerve", "correct": true}, {"label": "B", "text": "Ulnar nerve", "correct": false}, {"label": "C", "text": "Lateral popliteal nerve", "correct": false}, {"label": "D", "text": "Sciatic nerve", "correct": false}], "correct_answer": "A. Median nerve", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Solution:</strong></p><p>Median nerve Mononeuropathies are severe and of rapid onset, but they eventually recover. The nerves most commonly affected are the 3rd and 6th cranial nerves (resulting in diplopia), and the femoral and sciatic nerves. Rarely, involvement of other single nerves results in paresis and paraesthesiae in the thorax and trunk (truncal radiculopathies).</p>\n<p><strong>Highyeild:</strong></p><p>Nerve compression palsies are more common in diabetes, frequently affecting the median nerve and giving the clinical picture of carpal tunnel syndrome, and less commonly the ulnar nerve. Lateral popliteal nerve compression occasionally causes foot drop. Compression palsies may be more common because of glycosylation and thickening of connective tissue and/or because of increased susceptibility of nerves affected by diabetic microangiopathy. Nerve compression palsies are more common in diabetes, frequently affecting the median nerve and giving the clinical picture of carpal tunnel syndrome, and less commonly the ulnar nerve.</p>\n<p><strong>Random:</strong></p><p>Explanation for incorrect options: - Option: B. Less commonly the ulnar nerve. Option: C. Lateral popliteal nerve compression occasionally causes foot drop. Option: D. Rare .</p>\n<p><strong>Extraedge:</strong></p><p>Classification of diabetic neuropathy Somatic ‚óè Polyneuropathy: ‚óè Symmetrical, mainly sensory and distal ‚óè Asymmetrical, mainly motor and proximal (Including amyotrophy) ‚óè Mononeuropathy (including mononeuritis multiplex) Visceral (autonomic) ‚óè Cardiovascular ‚óè Gastrointestinal ‚óè Genitourinary ‚óè Sudomotor ‚óè Vasomotor ‚óè Pupillary</p>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "An arthropathy is characterized by early inflammation and then joint dislocation, subluxation and pathological fractures of the foot of neuropathic patients, often resulting in debilitating deformity. The X-ray is shown below. What is the most common cause of this condition?", "options": [{"label": "A", "text": "Syringomyelia", "correct": false}, {"label": "B", "text": "Spinal cord injury", "correct": false}, {"label": "C", "text": "Diabetes mellitus", "correct": true}, {"label": "D", "text": "Syphilis", "correct": false}], "correct_answer": "C. Diabetes mellitus", "question_images": ["https://dbmi-data.s3.ap-south-1.amazonaws.com/photos-1685619373233-QTDM048031IMG1.JPG"], "explanation_images": [], "explanation": "<p><strong>Solution:</strong></p><p>Diabetes mellitus Charcot neuroarthropathy can arise in any condition that causes neuropathy (including syphilis, spinal cord injury, syringomyelia etc.) but diabetes is the most common cause.</p>\n<p><strong>Highyeild:</strong></p><p>Acute Charcot neuroarthropathy almost always presents with signs of inflammation ‚Äì a hot, red, swollen foot. The initial x-ray may show bony destruction but is often normal. As about 40%of patients with a Charcot